Literature DB >> 21247684

Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic.

J Stephen Jones.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21247684     DOI： 10.1016/j.eururo.2011.01.007

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  12 in total

1.  Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.

Authors:  Yi Yin; Rui Li; Kangling Xu; Sentai Ding; Jeffrey Li; GuemHee Baek; Susmita G Ramanand; Sam Ding; Zhao Liu; Yunpeng Gao; Mohammed S Kanchwala; Xiangyi Li; Ryan Hutchinson; Xihui Liu; Solomon L Woldu; Chao Xing; Neil B Desai; Felix Y Feng; Sandeep Burma; Johann S de Bono; Scott M Dehm; Ram S Mani; Benjamin P C Chen; Ganesh V Raj
Journal:  Cancer Res       Date:  2017-07-28       Impact factor: 12.701

Review 2.  Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue.

Authors:  J G Baust; J C Bischof; S Jiang-Hughes; T J Polascik; D B Rukstalis; A A Gage; J M Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-01-27       Impact factor: 5.554

Review 3.  Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review.

Authors:  Giorgio Calleris; Giancarlo Marra; Ettore Dalmasso; Marco Falcone; Robert Jeffrey Karnes; Alessandro Morlacco; Marco Oderda; Rafael Sanchez-Salas; Francesco Soria; Paolo Gontero
Journal:  World J Urol       Date:  2019-04-06       Impact factor: 4.226

4.  The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol.

Authors:  Giancarlo Marra; Taimur T Shah; Daniele D'Agate; Alessandro Marquis; Giorgio Calleris; Luca Lunelli; Claudia Filippini; Marco Oderda; Marco Gatti; Massimo Valerio; Rafael Sanchez-Salas; Alberto Bossi; Juan Gomez-Rivas; Francesca Conte; Desiree Deandreis; Olivier Cussenot; Umberto Ricardi; Paolo Gontero
Journal:  Front Surg       Date:  2022-06-07

5.  Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer.

Authors:  Cristina Mariucci; Gianluca Ingrosso; Vittorio Bini; Simonetta Saldi; Marco Lupattelli; Alessandro Frattegiani; Elisabetta Perrucci; Isabella Palumbo; Lorenzo Falcinelli; Giuseppe Centofanti; Rita Bellavita; Cynthia Aristei
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-22

6.  Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells.

Authors:  A M Hirst; M S Simms; V M Mann; N J Maitland; D O'Connell; F M Frame
Journal:  Br J Cancer       Date:  2015-04-02       Impact factor: 7.640

7.  Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.

Authors:  Kathleen A Boyd; Rob J Jones; Jim Paul; Fiona Birrell; Andrew H Briggs; Hing Y Leung
Journal:  BMJ Open       Date:  2015-10-19       Impact factor: 2.692

8.  Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells.

Authors:  Engin Ulukaya; Fiona M Frame; Buse Cevatemre; Davide Pellacani; Hannah Walker; Vincent M Mann; Matthew S Simms; Michael J Stower; Veysel T Yilmaz; Norman J Maitland
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

Review 9.  Low temperature plasma: a novel focal therapy for localized prostate cancer?

Authors:  Adam M Hirst; Fiona M Frame; Norman J Maitland; Deborah O'Connell
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

10.  HDAC inhibitor confers radiosensitivity to prostate stem-like cells.

Authors:  F M Frame; D Pellacani; A T Collins; M S Simms; V M Mann; G D D Jones; M Meuth; R G Bristow; N J Maitland
Journal:  Br J Cancer       Date:  2013-11-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.